TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of 2 Doses of Aprepitant for the Prevention of Postoperative Nausea and Vomiting
Brief Summary: The purpose of this study is to assess the safety and efficacy of 2 doses of an approved drug for a new indication in the prevention of postoperative nausea and vomiting in patients receiving general anesthesia for open abdominal surgery requiring overnight hospital stay.


Options:
A: Arm Label: Ondansetron; Type: EXPERIMENTAL; Interventions: Drug: Ondansetron | Arm Label: Saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline | Intervention Type: DRUG; Name: Ondansetron; Assigned to Arm(s): Ondansetron | Intervention Type: DRUG; Name: Saline; Assigned to Arm(s): Saline
B: Intervention Type: DRUG; Name: MK0869, aprepitant; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Comparator: ondansetron IV; Assigned to Arm(s): N/A
C: Arm Label: Group A; Type: ACTIVE_COMPARATOR; Interventions: Drug: ramosetron with saline | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Drug: ramosetron with dexamethasone | Intervention Type: DRUG; Name: ramosetron with saline; Assigned to Arm(s): Group A | Intervention Type: DRUG; Name: ramosetron with dexamethasone; Assigned to Arm(s): Group B
D: Arm Label: dexamethasone; Type: PLACEBO_COMPARATOR; Interventions: Drug: Dexamethasone iv injection | Arm Label: dexamethasone, haloperiol 1mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone, haloperidol | Arm Label: dexamethasone + haloperidol 2mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone, haloperidol | Intervention Type: DRUG; Name: Dexamethasone iv injection; Assigned to Arm(s): dexamethasone | Intervention Type: DRUG; Name: Dexamethasone, haloperidol; Assigned to Arm(s): dexamethasone, haloperiol 1mg | Intervention Type: DRUG; Name: Dexamethasone, haloperidol; Assigned to Arm(s): dexamethasone + haloperidol 2mg

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Parallel-Group Study Conducted Under In-House Blinding Conditions to Determine the Safety, Tolerability and Efficacy of Aprepitant Regimen Compared to Ondansetron Regimen for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With High Dose Cisplatin in Cycle 1
Brief Summary: A multicenter trial to assess the safety and efficacy of an investigational drug in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with confirmed solid tumors who will be treated with a chemotherapy regimen that includes cisplatin. The study will evaluate the investigational drug for the treatment of CINV during the first cycle of treatment with cisplatin.


Options:
A: Arm Label: Netupitant and Palonosetron plus dexamethasone; Type: EXPERIMENTAL; Interventions: Drug: Netupitant and Palonosetron, Drug: Dexamethasone | Arm Label: Aprepitant and Palonosetron plus dexamethasone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aprepitant, Drug: Palonosetron, Drug: Dexamethasone | Intervention Type: DRUG; Name: Netupitant and Palonosetron; Assigned to Arm(s): Netupitant and Palonosetron plus dexamethasone | Intervention Type: DRUG; Name: Aprepitant; Assigned to Arm(s): Aprepitant and Palonosetron plus dexamethasone | Intervention Type: DRUG; Name: Palonosetron; Assigned to Arm(s): Aprepitant and Palonosetron plus dexamethasone | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Aprepitant and Palonosetron plus dexamethasone, Netupitant and Palonosetron plus dexamethasone
B: Intervention Type: DRUG; Name: Oral Casopitant (GW679769); Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: IV Casopitant (GW679769); Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: IV ondansetron hydrochloride; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Oral dexamethasone; Assigned to Arm(s): N/A
C: Arm Label: Aprepitant (MK-0869); Type: EXPERIMENTAL; Interventions: Drug: aprepitant, Drug: granisetron, Drug: dexamethasone | Arm Label: Standard Therapy; Type: PLACEBO_COMPARATOR; Interventions: Drug: Comparator: Placebo to aprepitant, Drug: dexamethasone, Drug: granisetron | Intervention Type: DRUG; Name: aprepitant; Assigned to Arm(s): Aprepitant (MK-0869) | Intervention Type: DRUG; Name: Comparator: Placebo to aprepitant; Assigned to Arm(s): Standard Therapy | Intervention Type: DRUG; Name: dexamethasone; Assigned to Arm(s): Standard Therapy | Intervention Type: DRUG; Name: granisetron; Assigned to Arm(s): Aprepitant (MK-0869), Standard Therapy | Intervention Type: DRUG; Name: dexamethasone; Assigned to Arm(s): Aprepitant (MK-0869)
D: Intervention Type: DRUG; Name: MK0869, aprepitant / Duration of Treatment: 3 days; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Comparator: ondansetron / Duration of Treatment: 4 days; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety and Efficacy of Pentavalent (G1, G2, G3, G4 , and P1) Human-Bovine Reassortant Rotavirus Vaccine in Healthy Infants
Brief Summary: This study was designed to evaluate the safety of the investigational rotavirus vaccine and the efficacy to prevent rotavirus gastroenteritis.


Options:
A: Intervention Type: BIOLOGICAL; Name: HRV vaccine; Assigned to Arm(s): N/A
B: Arm Label: rotavirus vaccine 116E 1 X 10(4); Type: EXPERIMENTAL; Interventions: Biological: Oral Rotavirus Vaccine 116E Live Attenuated | Arm Label: rotavirus vaccine 116E 1 X 10(5); Type: EXPERIMENTAL; Interventions: Biological: Oral Rotavirus Vaccine 116E Live Attenuated | Intervention Type: BIOLOGICAL; Name: Oral Rotavirus Vaccine 116E Live Attenuated; Assigned to Arm(s): rotavirus vaccine 116E 1 X 10(4), rotavirus vaccine 116E 1 X 10(5)
C: Arm Label: Rotavirus vaccine (BRV-PV); Type: EXPERIMENTAL; Interventions: Biological: Rotavirus vaccine (BRV-PV) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Rotavirus vaccine (BRV-PV); Assigned to Arm(s): Rotavirus vaccine (BRV-PV) | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: Rotateq™ | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: Comparator: Placebo | Intervention Type: BIOLOGICAL; Name: Rotateq™; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Comparator: Placebo; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety and Efficacy of Pentavalent (G1, G2, G3, G4 , and P1) Human-Bovine Reassortant Rotavirus Vaccine in Healthy Infants
Brief Summary: This study was designed to evaluate the safety of the investigational rotavirus vaccine and the efficacy to prevent rotavirus gastroenteritis.


Options:
A: Arm Label: Co-administration Group; Type: EXPERIMENTAL; Interventions: Biological: Squarekids, Biological: Rotarix | Arm Label: Staggered Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Squarekids, Biological: Rotarix | Intervention Type: BIOLOGICAL; Name: Squarekids; Assigned to Arm(s): Co-administration Group, Staggered Group | Intervention Type: BIOLOGICAL; Name: Rotarix; Assigned to Arm(s): Co-administration Group, Staggered Group
B: Intervention Type: BIOLOGICAL; Name: Rotavirus (vaccine); Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: Rotateq™ | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: Comparator: Placebo | Intervention Type: BIOLOGICAL; Name: Rotateq™; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Comparator: Placebo; Assigned to Arm(s): 2
D: Arm Label: Vaccine Arm; Type: EXPERIMENTAL; Interventions: Biological: Live Attenuated Pentavalent (G1-G2-G3-G4-G9) Human X Bovine Reassortant Rotavirus Vaccine (BRV-PV) | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: BIOLOGICAL; Name: Live Attenuated Pentavalent (G1-G2-G3-G4-G9) Human X Bovine Reassortant Rotavirus Vaccine (BRV-PV); Assigned to Arm(s): Vaccine Arm | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety and Efficacy of Pentavalent (G1, G2, G3, G4 , and P1) Human-Bovine Reassortant Rotavirus Vaccine in Healthy Infants
Brief Summary: This study was designed to evaluate the safety of the investigational rotavirus vaccine and the efficacy to prevent rotavirus gastroenteritis.


Options:
A: Arm Label: Rotavirus vaccine (BRV-PV); Type: EXPERIMENTAL; Interventions: Biological: Rotavirus vaccine (BRV-PV) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Rotavirus vaccine (BRV-PV); Assigned to Arm(s): Rotavirus vaccine (BRV-PV) | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: BIOLOGICAL; Name: Live attenuated human rotavirus vaccine; Assigned to Arm(s): N/A
C: Intervention Type: BIOLOGICAL; Name: 2-dose oral live attenuated G1P[8] human rotavirus vaccine; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: Rotateq™ | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: Comparator: Placebo | Intervention Type: BIOLOGICAL; Name: Rotateq™; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Comparator: Placebo; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of 2 Doses of Aprepitant for the Prevention of Postoperative Nausea and Vomiting
Brief Summary: The purpose of this study is to assess the safety and efficacy of 2 doses of an approved drug for a new indication in the prevention of postoperative nausea and vomiting in patients receiving general anesthesia for open abdominal surgery requiring overnight hospital stay.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Isotonic NaCl | Arm Label: dexamethasone; Type: EXPERIMENTAL; Interventions: Drug: dexamethasone phosphate | Intervention Type: DRUG; Name: dexamethasone phosphate; Assigned to Arm(s): dexamethasone | Intervention Type: DRUG; Name: Isotonic NaCl; Assigned to Arm(s): Placebo
B: Arm Label: A, 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: A, 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethason Helvepharm ® | Intervention Type: DRUG; Name: Dexamethason Helvepharm ®; Assigned to Arm(s): A, 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A, 1
C: Arm Label: Gabapentin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Gabapentin | Arm Label: ramosetron; Type: ACTIVE_COMPARATOR; Interventions: Drug: Ramosetron | Arm Label: Gabapentin and ramosetron; Type: ACTIVE_COMPARATOR; Interventions: Drug: Gabapentin and Ramosetron | Intervention Type: DRUG; Name: Gabapentin; Assigned to Arm(s): Gabapentin | Intervention Type: DRUG; Name: Ramosetron; Assigned to Arm(s): ramosetron | Intervention Type: DRUG; Name: Gabapentin and Ramosetron; Assigned to Arm(s): Gabapentin and ramosetron
D: Intervention Type: DRUG; Name: MK0869, aprepitant; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Comparator: ondansetron IV; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Multicenter, Double-Blind, Randomized, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Dose of Ertapenem Sodium (MK0826) Versus Cefotetan for the Prophylaxis of Surgical Site Infection Following Elective Colorectal Surgery
Brief Summary: The objective of this study is to evaluate the safety and efficacy of a one time dose of an intravenous marketed drug being evaluated for a new indication as compared to a marketed drug already approved for the prevention of surgical site infection following colorectal surgery.


Options:
A: Intervention Type: PROCEDURE; Name: Intra-peritoneal antibiotic lavage; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Cefmetazole (drug); Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: gentamicin-collagen sponge dipped in saline | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: gentamicin-collagen sponge dipped in saline; Assigned to Arm(s): 1
D: Intervention Type: DRUG; Name: MK0826, ertapenem sodium; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Comparator: cefotetan; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Randomized, Double-Blind Study to Evaluate the Lipid-Altering Efficacy and Safety of the Ezetimibe/Simvastatin Combination Tablet Versus Rosuvastatin in Patients With Primary Hypercholesterolemia
Brief Summary: A 10-week study to compare the reduction in cholesterol following treatment with two different marketed drugs in patients with hypercholesterolemia.


Options:
A: Intervention Type: DRUG; Name: Rosuvastatin; Assigned to Arm(s): N/A
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: ABT-335, Drug: Simvastatin | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: ABT-335, Drug: Simvastatin | Arm Label: C; Type: PLACEBO_COMPARATOR; Interventions: Drug: ABT-335, Drug: Placebo | Arm Label: D; Type: PLACEBO_COMPARATOR; Interventions: Drug: Simvastatin, Drug: Placebo | Arm Label: E; Type: PLACEBO_COMPARATOR; Interventions: Drug: Simvastatin, Drug: Placebo | Arm Label: F; Type: PLACEBO_COMPARATOR; Interventions: Drug: Simvastatin, Drug: Placebo | Intervention Type: DRUG; Name: ABT-335; Assigned to Arm(s): A, B, C | Intervention Type: DRUG; Name: Simvastatin; Assigned to Arm(s): A, B, D, E, F | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): C, D, E, F
C: Intervention Type: DRUG; Name: rosuvastatin; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: MK0653A, ezetimibe (+) simvastatin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Comparator: Rosuvastatin; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: UW STAART Center of Excellence
Brief Summary: This study will identify factors that distinguish children with autism from children with developmental delay and those with normal development and study the efficacy of intensive behavioral therapy in children with autism.


Options:
A: Intervention Type: BEHAVIORAL; Name: Joint attention intervention; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Early intervention blending several tx approaches, w/ focus | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Early intervention blending several treatment approaches | Intervention Type: BEHAVIORAL; Name: Early intervention blending several tx approaches, w/ focus; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Early intervention blending several treatment approaches; Assigned to Arm(s): 2
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intensive behavioral therapy | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intensive behavioral therapy; Assigned to Arm(s): 1
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Social skills training targeting children with autism | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Social skills training of peers without autism | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Combination treatment of social skills/education about autism | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual training | Intervention Type: BEHAVIORAL; Name: Social skills training targeting children with autism; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Social skills training of peers without autism; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Combination treatment of social skills/education about autism; Assigned to Arm(s): 3 | Intervention Type: BEHAVIORAL; Name: Usual training; Assigned to Arm(s): 4

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: UW STAART Center of Excellence
Brief Summary: This study will identify factors that distinguish children with autism from children with developmental delay and those with normal development and study the efficacy of intensive behavioral therapy in children with autism.


Options:
A: Arm Label: ESI--Individual PII First Condition; Type: EXPERIMENTAL; Interventions: Behavioral: Early Social Interaction Project- PII, Behavioral: Early Social Interaction Project- IES | Arm Label: ESI--Group IES First Condition; Type: EXPERIMENTAL; Interventions: Behavioral: Early Social Interaction Project- PII, Behavioral: Early Social Interaction Project- IES | Intervention Type: BEHAVIORAL; Name: Early Social Interaction Project- PII; Assigned to Arm(s): ESI--Group IES First Condition, ESI--Individual PII First Condition | Intervention Type: BEHAVIORAL; Name: Early Social Interaction Project- IES; Assigned to Arm(s): ESI--Group IES First Condition, ESI--Individual PII First Condition
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intensive behavioral therapy | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intensive behavioral therapy; Assigned to Arm(s): 1
C: Arm Label: Pivotal Response Training (PRT); Type: EXPERIMENTAL; Interventions: Behavioral: Pivotal Response Training (PRT) | Arm Label: Parent Education Group (PEG); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Parent Education Group (PEG) | Intervention Type: BEHAVIORAL; Name: Pivotal Response Training (PRT); Assigned to Arm(s): Pivotal Response Training (PRT) | Intervention Type: BEHAVIORAL; Name: Parent Education Group (PEG); Assigned to Arm(s): Parent Education Group (PEG)
D: Intervention Type: BEHAVIORAL; Name: Joint attention intervention; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: UW STAART Center of Excellence
Brief Summary: This study will identify factors that distinguish children with autism from children with developmental delay and those with normal development and study the efficacy of intensive behavioral therapy in children with autism.


Options:
A: Intervention Type: BEHAVIORAL; Name: Joint attention intervention; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Early intervention blending several tx approaches, w/ focus | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Early intervention blending several treatment approaches | Intervention Type: BEHAVIORAL; Name: Early intervention blending several tx approaches, w/ focus; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Early intervention blending several treatment approaches; Assigned to Arm(s): 2
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intensive behavioral therapy | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intensive behavioral therapy; Assigned to Arm(s): 1
D: Intervention Type: BEHAVIORAL; Name: Caregiver joint attention intervention; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Behavior Enhances Drug Reduction of Incontinence
Brief Summary: The primary aim of this study is to test if the addition of behavioral treatment to drug therapy for the treatment of urge incontinence will increase the number of patients who can discontinue drug therapy and sustain a significant reduction of incontinence.


Options:
A: Arm Label: Tät®II Treatment app; Type: EXPERIMENTAL; Interventions: Device: Tät®II Treatment app | Arm Label: Tät®II Information app; Type: OTHER; Interventions: Device: Tät®II Information app | Intervention Type: DEVICE; Name: Tät®II Information app; Assigned to Arm(s): Tät®II Information app | Intervention Type: DEVICE; Name: Tät®II Treatment app; Assigned to Arm(s): Tät®II Treatment app
B: Arm Label: Behavioral Training; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral training | Arm Label: Drug Therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxybutynin chloride, extended-release | Intervention Type: BEHAVIORAL; Name: Behavioral training; Assigned to Arm(s): Behavioral Training | Intervention Type: DRUG; Name: Oxybutynin chloride, extended-release; Assigned to Arm(s): Drug Therapy
C: Arm Label: Combination therapy; Type: EXPERIMENTAL; Interventions: Drug: Tolterodine, Behavioral: Behavioral training | Arm Label: Drug therapy alone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tolterodine | Intervention Type: DRUG; Name: Tolterodine; Assigned to Arm(s): Combination therapy, Drug therapy alone | Intervention Type: BEHAVIORAL; Name: Behavioral training; Assigned to Arm(s): Combination therapy
D: Arm Label: Burch; Type: OTHER; Interventions: Procedure: Burch Modified Tanagho | Arm Label: Sling; Type: OTHER; Interventions: Procedure: Autologous Fascia Sling | Intervention Type: PROCEDURE; Name: Burch Modified Tanagho; Assigned to Arm(s): Burch | Intervention Type: PROCEDURE; Name: Autologous Fascia Sling; Assigned to Arm(s): Sling

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Behavior Enhances Drug Reduction of Incontinence
Brief Summary: The primary aim of this study is to test if the addition of behavioral treatment to drug therapy for the treatment of urge incontinence will increase the number of patients who can discontinue drug therapy and sustain a significant reduction of incontinence.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Solifenacin succinate | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Simplified bladder training | Intervention Type: DRUG; Name: Solifenacin succinate; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Simplified bladder training; Assigned to Arm(s): 2
B: Arm Label: acupuncture; Type: EXPERIMENTAL; Interventions: Procedure: acupuncture | Arm Label: Solifenacin plus PFMT; Type: ACTIVE_COMPARATOR; Interventions: Drug: solifenacin, Procedure: PFMT | Intervention Type: PROCEDURE; Name: acupuncture; Assigned to Arm(s): acupuncture | Intervention Type: DRUG; Name: solifenacin; Assigned to Arm(s): Solifenacin plus PFMT | Intervention Type: PROCEDURE; Name: PFMT; Assigned to Arm(s): Solifenacin plus PFMT
C: Arm Label: Combination therapy; Type: EXPERIMENTAL; Interventions: Drug: Tolterodine, Behavioral: Behavioral training | Arm Label: Drug therapy alone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tolterodine | Intervention Type: DRUG; Name: Tolterodine; Assigned to Arm(s): Combination therapy, Drug therapy alone | Intervention Type: BEHAVIORAL; Name: Behavioral training; Assigned to Arm(s): Combination therapy
D: Arm Label: bladdertraining group; Type: EXPERIMENTAL; Interventions: Behavioral: bladdertraining in groups | Arm Label: bladdertraining individually; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: bladdertraining individually | Intervention Type: BEHAVIORAL; Name: bladdertraining in groups; Assigned to Arm(s): bladdertraining group | Intervention Type: BEHAVIORAL; Name: bladdertraining individually; Assigned to Arm(s): bladdertraining individually

Answer: C